Literature DB >> 23100960

Systemic mastocytosis with acute myelomonocytic leukemia: a case report.

Rakhee Kar1, Seema Rao, Hara Prasad Pati.   

Abstract

Bone marrow mastocytosis may be associated with many clonal non mast cell hematological neoplasms and its association with acute myeloid leukemia especially with t (8; 21) has been described. We describe an interesting case of coexistence of systemic mastocytosis with acute myelomonocytic leukemia in a young child. Diagnosis of acute myelomonocytic leukemia was based on bone marrow aspirate findings coupled with cytochemistry. Systemic mastocytosis was diagnosed on the basis of bone marrow biopsy findings showing blasts as well as multifocal dense mast cell infiltrates with spindling and atypical morphology which was confirmed on toluidine blue staining.

Entities:  

Keywords:  Acute myeloid leukemia; Systemic mastocytosis; Toluidine blue

Year:  2009        PMID: 23100960      PMCID: PMC3475428          DOI: 10.1007/s12288-008-0044-5

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  14 in total

1.  Acute myeloblastic leukaemia with differentiation to myeloblasts and mast cell blasts.

Authors:  N Varma; S Varma; B Wilkins
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

Review 2.  Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms.

Authors:  A Tefferi; J W Vardiman
Journal:  Leukemia       Date:  2007-09-20       Impact factor: 11.528

3.  Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation.

Authors:  Wolfgang R Sperr; Johannes Drach; Alexander W Hauswirth; Jutta Ackermann; Margit Mitterbauer; Gerlinde Mitterbauer; Manuela Foedinger; Christa Fonatsch; Ingrid Simonitsch-Klupp; Peter Kalhs; Peter Valent
Journal:  Clin Cancer Res       Date:  2005-10-01       Impact factor: 12.531

4.  Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.

Authors:  Vinod A Pullarkat; Carlos Bueso-Ramos; Raymond Lai; Steven Kroft; Carla S Wilson; Sheeja T Pullarkat; Xiangdong Bu; Maung Thein; M Lee; Russell K Brynes
Journal:  Am J Hematol       Date:  2003-05       Impact factor: 10.047

5.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Authors:  Jan Cools; Daniel J DeAngelo; Jason Gotlib; Elizabeth H Stover; Robert D Legare; Jorges Cortes; Jeffrey Kutok; Jennifer Clark; Ilene Galinsky; James D Griffin; Nicholas C P Cross; Ayalew Tefferi; James Malone; Rafeul Alam; Stanley L Schrier; Janet Schmid; Michal Rose; Peter Vandenberghe; Gregor Verhoef; Marc Boogaerts; Iwona Wlodarska; Hagop Kantarjian; Peter Marynen; Steven E Coutre; Richard Stone; D Gary Gilliland
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

6.  Mast cell disease associated with acute myeloid leukemia: detection of a new c-kit mutation Asp816His.

Authors:  V A Pullarkat; S T Pullarkat; D C Calverley; R K Brynes
Journal:  Am J Hematol       Date:  2000-12       Impact factor: 10.047

Review 7.  Mastocytosis: pathology, genetics, and current options for therapy.

Authors:  Peter Valent; Cem Akin; Wolfgang R Sperr; Matthias Mayerhofer; Manuela Födinger; Robert Fritsche-Polanz; Karl Sotlar; Luis Escribano; Michel Arock; Hans-Peter Horny; Dean D Metcalfe
Journal:  Leuk Lymphoma       Date:  2005-01

8.  Systemic mastocytosis associated with acute myeloid leukemia: case report and implications for disease pathogenesis.

Authors:  Luis Escribano; Andrés Garca-Montero; Rosa Núñez-López; Javier López-Jiménez; Julia Almeida; Aranzazu Prados; Alberto Orfao
Journal:  J Allergy Clin Immunol       Date:  2004-07       Impact factor: 10.793

9.  Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusion.

Authors:  Idoya Lahortiga; Cem Akin; Jan Cools; Todd M Wilson; Nicole Mentens; Diane C Arthur; Irina Maric; Pierre Noel; Can Kocabas; Peter Marynen; Lawrence S Lessin; Iwona Wlodarska; Jamie Robyn; Dean D Metcalfe
Journal:  Haematologica       Date:  2008-01       Impact factor: 9.941

10.  Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.

Authors:  H-P Horny; K Sotlar; W R Sperr; P Valent
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.